You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0223 Elevated MTORC1 signature in B cells from sjÖgren's syndrome patients correlates with B cell hyperactivity that is abrogated by MTOR inhibition: a novel therapeutic strategy to halt B cell hyperactivity in PSS?

Article metrics

Article menu

Download PDFPDF

Poster Presentations
SLE, Sjögren's and APS - etiology, pathogenesis and animal models
THU0223 Elevated MTORC1 signature in B cells from sjÖgren's syndrome patients correlates with B cell hyperactivity that is abrogated by MTOR inhibition: a novel therapeutic strategy to halt B cell hyperactivity in PSS?
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017601
Jul 20171000
Aug 20171200
Sep 20171202
Oct 2017803
Nov 2017801
Dec 20171201
Jan 20181401
Feb 20181401
Mar 20183001
Apr 2018200
May 2018600
Jun 20181200
Jul 2018800
Aug 20181002
Sep 20181202
Oct 2018200
Nov 20181005
Dec 2018401
Jan 2019200
Mar 2019203
Apr 2019004
May 2019201
Jun 2019603
Jul 2019203
Aug 2019803
Sep 2019201
Oct 2019203
Nov 2019203
Dec 2019200
Feb 2020001
Mar 2020001
Apr 2020001
May 2020801
Jun 2020601
Jul 2020600
Aug 2020203
Sep 2020800
Oct 2020202
Dec 2020600
Jan 2021003
Feb 2021001
Mar 2021001
Apr 2021401
May 2021206
Jul 2021001
Aug 2021002
Sep 2021003
Oct 20217016
Nov 20212012
Dec 2021001
Feb 2022201
Mar 2022001
Apr 2022804
May 20221007
Jun 20221603
Jul 20221303
Aug 2022803
Sep 2022204
Oct 2022603
Nov 2022402
Dec 2022800
Jan 20231002
Feb 2023200
Mar 2023800
May 2023103
Jul 2023303
Sep 2023001
Nov 2023200
Dec 20231100
Jan 2024200
Feb 2024806
Mar 20242026
Total4010174